Tenaya Therapeutics, Inc. (TNYA)
0.6687
-0.03
(-4.10%)
USD |
NASDAQ |
Aug 24, 16:00
0.6687
0.00 (0.00%)
After-Hours: 20:00
Tenaya Therapeutics Total Assets (Quarterly) : 93.54M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 93.54M |
| March 31, 2026 | 135.07M |
| December 31, 2025 | 149.32M |
| September 30, 2025 | 104.98M |
| June 30, 2025 | 122.15M |
| March 31, 2025 | 143.95M |
| December 31, 2024 | 123.33M |
| September 30, 2024 | 140.58M |
| June 30, 2024 | 163.18M |
| March 31, 2024 | 184.90M |
| December 31, 2023 | 170.52M |
| September 30, 2023 | 193.40M |
| Date | Value |
|---|---|
| June 30, 2023 | 220.75M |
| March 31, 2023 | 245.34M |
| December 31, 2022 | 278.94M |
| September 30, 2022 | 226.31M |
| June 30, 2022 | 255.93M |
| March 31, 2022 | 281.50M |
| December 31, 2021 | 316.65M |
| September 30, 2021 | 331.81M |
| June 30, 2021 | 156.91M |
| March 31, 2021 | 159.84M |
| December 31, 2020 | 148.25M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 857.16M |
| Anavex Life Sciences Corp. | 128.77M |
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 24.13M |
| Shareholders Equity (Quarterly) | 69.41M |
| Debt to Equity Ratio | 0.0569 |
| Current Ratio | 4.522 |
| Net Debt Paydown Yield | 1.08% |